期刊文献+

应用基因芯片方法检测结核分枝杆菌利福平和异烟肼的耐药性 被引量:19

Rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid by gene chip
暂未订购
导出
摘要 目的应用基因芯片方法检测结核分枝杆菌(Mycobacterium tuberculosis,Mtb)对利福平和异烟肼的耐受性,评价其临床应用价值。方法应用聚合酶链反应(polymerase chain reaction,PCR)扩增-基因芯片杂交的方法检测经常规药敏实验证实的30株Mtb利福平和异烟肼敏感株和50株耐利福平和异烟肼分离株的rpoB基因及katG和inhA基因突变,同时以PCR-直接测序法为对照。结果应用PCR-基因芯片与基因测序方法检测30株Mtb利福平敏感株rpoB基因和异烟肼敏感株katG基因和inhA基因均为野生型。50株Mtb利福平耐药株中,PCR-基因芯片与基因测序分析3株rpoB基因均为野生型,41株均为突变型;6株PCR-基因芯片与基因测序结果不一致。50株Mtb异烟肼耐药株中,PCR-基因芯片与基因测序分析16株katG基因和30株inhA基因均为野生型,31株katG基因均为315位密码子突变,7株inhA基因均为-15位突变型,其中2株为katG和inhA双重突变;3株katG和13株inhAPCR-基因芯片与基因测序结果不一致。结论应用PCR-基因芯片方法可快速、有效地检出大多数Mtb耐多药分离株,指导临床用药。 Objective To detect Mycobacterium tuberculosis(Mtb)resistance to rifampicin(RIF) and isoniazid(INH) by gene chip,and to evaluate their clinical values. Methods Thirty RIF-and INH-susceptible and 50 RIF-and INH-resistant clinical isolates in Mtb were analyzed the mutations of rpoB、katG and inhA genes by(PCR)-gene chip and DNA sequencing. Results The rpoB、katG and inhA genes from 30 RIF-and INH-susceptible isolates of Mtb were all wild types by PCR-gene chip and DNA sequencing.Of 50 RIF-resistant clinical isolates,3 had wild types of ropB genes,and 41 had ropB mutations by PCR-gene chip and DNA sequencing.Six had inconsistent results between PCR-gene chip and DNA sequencing.Of 50 INH-resistant clinical isolates,16 had wild types of katG genes,and 31 had katG mutations on codon 315;30 had wild types of inhA genes,and 7 had inhA mutations at position-15.KatG results of 3 isolates and inhA results of 13 isolates were inconsistent between PCR-gene chip and DNA sequencing. Conclusion PCR-gene chip might be a rapid and effective method for the detection of Mtb multi-drug-resistant isolates.
出处 《中国防痨杂志》 CAS 2011年第10期680-685,共6页 Chinese Journal of Antituberculosis
基金 北京市科技重大专项重点项目(Z09050700940904) "十一五"国家重大科技专项(2008ZX10003-001)
关键词 分枝杆菌 结核 利福平 异烟肼 抗药性 细菌 寡核苷酸序列分析 Mycobacterium tuberculosis Rifampicin Isoniazid Drug resistance bacterial Oligonucletide array sequence analysis
  • 相关文献

参考文献16

  • 1Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights (Review). Clin Microbiol Rev, 1995, 8(4) 496-514.
  • 2Nachamkin I, Kang C, Weinstein MP. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis, 1997,24(5):894-900.
  • 3Jou R, Chen HY, Chiang CY, et al. Genetic diversity of mul- tidrug-resistant Mycobacterium tuberculosis isolates and identifi- cation of 11 novel rpoB alleles in Taiwan. J Clin Microbiol, 2005, 43(3) : 1390-1394.
  • 4Bolotin S, Alexander DC, Chedore P, et al. Molecular charac- terization of drug-resistant MycobacteTum tuberculosis isolates from Ontario, Canada. J Antimicrob Chemother, 2009,64 (2) : 263-266.
  • 5Musser JM, Kapur V, Williams DL,et al. Characterization o{ the catalase-peroxidase gene (katG) and inhA locus in isonia- zid-resistant and -susceptible strains of Mycobacterium tubercu- losis by automated DNA sequencing restricted array of muta- tions associated with drug resistance. J Infect Dis, 1996,173 (1) : 196-202.
  • 6Luckner SR, Liu N, am Ende CW, et al. A slow, tight bind- ing inhibitor of InhA, the enoyl-aeyl carrier protein reductase from Mycobacterium tuberculosis. J Biol Chem, 2010,285 (19) : 14330-14337.
  • 7Dessen A, Qu6mard A, Blanchard JS, et al. Crystal structure and function of the isoniazid target of Mycobacterium tuberculo- sis. Science,1995,267(5204): 1638-1641.
  • 8Drobniewski FA, Watterson SA, Wilson SM, et al. A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin re- sistance in Mycobacterium tuberculosis. J Med MicrobioI, 2000, 49(3) :271-278.
  • 9Chaoui I, Sabouni R, Kourout M, et al. Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tu- berculosis isolates from Morocco. J Infect Dev Ctries, 2009,3 (4) 278-284.
  • 10Banerjee A, Dubnau E, Quemard A,et al. InhA, a gene enco- ding a target for isoniazid and ethionamide in Mycobacterium tu- berculosis. Science, 1994, 263(5144) : 227-230.

二级参考文献38

  • 1崔振玲,景奉香,胡忠义,吴自荣,赵建龙.基因芯片检测结核分枝杆菌利福平和异烟肼耐药性研究[J].中华结核和呼吸杂志,2004,27(7):439-441. 被引量:31
  • 2端木和运,张钢,邓为群.DNA芯片法检测耐多药结核分支杆菌耐药性[J].临床医学,2003,23(5):25-26. 被引量:6
  • 3结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:803
  • 4刘佳文,申阿东,孙桂芝.耐异烟肼结核分枝杆菌临床分离株耐药基因突变及其分子流行病学调查研究[J].临床肺科杂志,2007,12(6):567-569. 被引量:4
  • 5Vladyslav Nikolayevskyy, Yanina Balabanova, Tatyana Simak, Nadezhda Malomanova, Ivan Fedorin, Francis Drobniewski. Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation[J]. BMC Clinical Pathology, 2009, 9:2.
  • 6Freddie Bwanga, Sven Hoffner, Melles Haile, Moses L Joloba. Direct susceptibility testing for multi drug resistant tubereulosis: A meta-analysis[J]. BMC Infect Dis, 2009, 9: 67.
  • 7Paolo Miotto, Nuccia Saleri, Mathurin Dembele, Martial Ouedraogo, Gisele Badoum, Gabriele Pinsi, Giovanni B Migliori, Alberto Matteelli, Daniela M Cirillo. Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso[J]. BMC Infect Dis, 2009, 9.. 142.
  • 8Doris Hillemann, Sabine Rusch-Gerdes, Elvira Richter. Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical Specimens[J]. J Clin Microbiol, 2007, 45(8):2635-2640.
  • 9A Lacoma, N Garcia-Sierra, C Prat, J Ruiz-Manzano, L Haba, S Ros6s, J Maldonado, J Dominguez. GenoType MTBDRplus Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Samples [J]. J Clin Microbiol, 2008, 46(11): 3660-3667.
  • 10Bloch AB,Cauthen GM,Onorato IM0 et al. Nationwide survey of drug-resistant tuberculosis in the United States[J]. JAMA,1994,271(9):665-671.

共引文献36

同被引文献173

引证文献19

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部